MacPherson M - Search Results

1

Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.

Li J, Lovern M, Green ML, Chiu J, Zhou D, Comisar C, Xiong Y, Hing J, MacPherson M, Wright JG, Riccobene T, Carrothers TJ, Das S. Li J, et al. Among authors: macpherson m. Clin Transl Sci. 2019 Mar;12(2):151-163. doi: 10.1111/cts.12585. Epub 2018 Sep 28. Clin Transl Sci. 2019. PMID: 30221827 Free PMC article.

2

Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers.

Dimelow R, Wright JG, MacPherson M, Newell P, Das S. Dimelow R, et al. Among authors: macpherson m. Drugs R D. 2018 Sep;18(3):221-230. doi: 10.1007/s40268-018-0241-0. Drugs R D. 2018. PMID: 30054895 Free PMC article. Clinical Trial.

3

Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.

Nichols WW, Stone GG, Newell P, Broadhurst H, Wardman A, MacPherson M, Yates K, Riccobene T, Critchley IA, Das S. Nichols WW, et al. Among authors: macpherson m. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e02590-17. doi: 10.1128/AAC.02590-17. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30061279 Free PMC article.

4

Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.

Cristinacce A, Wright JG, Macpherson M, Iaconis J, Das S. Cristinacce A, et al. Among authors: macpherson m. Diagn Microbiol Infect Dis. 2021 Apr;99(4):115292. doi: 10.1016/j.diagmicrobio.2020.115292. Epub 2020 Dec 13. Diagn Microbiol Infect Dis. 2021. PMID: 33360809 Free article.

5

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.

Das S, Riccobene T, Carrothers TJ, Wright JG, MacPherson M, Cristinacce A, McFadyen L, Xie R, Luckey A, Raber S. Das S, et al. Among authors: macpherson m. Eur J Clin Pharmacol. 2024 Apr;80(4):529-543. doi: 10.1007/s00228-023-03609-x. Epub 2024 Jan 22. Eur J Clin Pharmacol. 2024. PMID: 38252170 Free PMC article. Clinical Trial.

6

Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia.

Macpherson M, Hamrén B, Braamskamp MJ, Kastelein JJ, Lundström T, Martin PD. Macpherson M, et al. Eur J Clin Pharmacol. 2016 Jan;72(1):19-27. doi: 10.1007/s00228-015-1946-4. Epub 2015 Sep 21. Eur J Clin Pharmacol. 2016. PMID: 26387811 Clinical Trial.

7

A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers.

Cantarini MV, Macpherson MP, Marshall AL, Robinson AV, Bailey CJ. Cantarini MV, et al. Cancer Chemother Pharmacol. 2005 Dec;56(6):557-62. doi: 10.1007/s00280-005-1007-2. Epub 2005 Jul 23. Cancer Chemother Pharmacol. 2005. PMID: 16041611 Clinical Trial.

8

Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.

Lamont E, Seaton RA, Macpherson M, Semple L, Bell E, Thomson AH. Lamont E, et al. Among authors: macpherson m. J Antimicrob Chemother. 2009 Jul;64(1):181-7. doi: 10.1093/jac/dkp147. Epub 2009 May 2. J Antimicrob Chemother. 2009. PMID: 19411678

9

The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib.

Horak J, White J, Harris AL, Verrill M, Carmichael J, Holt A, Cantarini M, Macpherson M, Swaisland A, Swaisland H, Twelves C. Horak J, et al. Among authors: macpherson m. Cancer Chemother Pharmacol. 2011 Dec;68(6):1485-95. doi: 10.1007/s00280-011-1611-2. Epub 2011 Apr 13. Cancer Chemother Pharmacol. 2011. PMID: 21487718

10

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).

Pritchard KI, Rolski J, Papai Z, Mauriac L, Cardoso F, Chang J, Panasci L, Ianuli C, Kahan Z, Fukase K, Lindemann JP, Macpherson MP, Neven P. Pritchard KI, et al. Breast Cancer Res Treat. 2010 Sep;123(2):453-61. doi: 10.1007/s10549-010-1022-9. Epub 2010 Jul 15. Breast Cancer Res Treat. 2010. PMID: 20632084 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page